Vice Provost and Dean of Research


Showing 501-600 of 1,742 Results

  • Sai Folmsbee, MD, PhD

    Sai Folmsbee, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsMy current research interest is the intersection of psychiatry and neuroimmunology. I am currently collaborating with Stanford Neuroimmunology in a retrospective analysis of patient data to determine the relationship between psychaitric medications and clinical outcomes in hospitalized patients with mutliple sclerosis, autoimmune encephalitis, and neuromyelitis optica.

  • James Ford

    James Ford

    Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsMammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA damage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.

  • Polly Fordyce

    Polly Fordyce

    Associate Professor of Bioengineering and of Genetics

    Current Research and Scholarly InterestsThe Fordyce Lab is focused on developing new instrumentation and assays for making quantitative, systems-scale biophysical measurements of molecular interactions. Current research in the lab is focused on three main platforms: (1) arrays of valved reaction chambers for high-throughput protein expression and characterization, (2) spectrally encoded beads for multiplexed bioassays, and (3) sortable droplets and microwells for single-cell assays.

  • Vasiliki Fouka

    Vasiliki Fouka

    Bing Professor of Human Biology, Associate Professor of Political Science and Senior Fellow at the Stanford Institute for Economic Policy Research

    BioVasiliki Fouka is an Associate Professor of Political Science, a Senior Fellow at the Stanford Institute for Economic Policy Research (SIEPR) and a Faculty Research Fellow at the National Bureau of Economic Research (NBER).

    Her research interests lie at the intersection of political economy and political behavior. She uses historical and contemporary data to understand what shapes social identities in the short and long run and the implications of that for political and economic behavior and policy design. Major applications of her research include immigrant assimilation, the determinants of prejudice against ethnic and racial minorities, and intergroup conflict.

    Her articles have been published in leading journals in political science and economics, including the American Political Science Review, the Annual Review of Political Science and the Review of Economic Studies.

  • Michael B. Fowler, MBBS, FRCP

    Michael B. Fowler, MBBS, FRCP

    Professor of Medicine (Cardiovascular), Emeritus

    Current Research and Scholarly InterestsAdrenergic nervous system; beta-adrenergic function in, heart failure; drugs in heart failure.

  • Emily Fox

    Emily Fox

    Professor of Statistics and of Computer Science

    BioEmily Fox is a Professor in the Departments of Statistics and Computer Science at Stanford University. Prior to Stanford, she was the Amazon Professor of Machine Learning in the Paul G. Allen School of Computer Science & Engineering and Department of Statistics at the University of Washington. From 2018-2021, Emily led the Health AI team at Apple, where she was a Distinguished Engineer. Before joining UW, Emily was an Assistant Professor at the Wharton School Department of Statistics at the University of Pennsylvania. She earned her doctorate from Electrical Engineering and Computer Science (EECS) at MIT where her thesis was recognized with EECS' Jin-Au Kong Outstanding Doctoral Thesis Prize and the Leonard J. Savage Award for Best Thesis in Applied Methodology.

    Emily has been awarded a CZ Biohub Investigator Award, Presidential Early Career Award for Scientists and Engineers (PECASE), a Sloan Research Fellowship, ONR Young Investigator Award, and NSF CAREER Award. Her research interests are in modeling complex time series arising in health, particularly from health wearables and neuroimaging modalities.

  • Paige Fox, MD, PhD, FACS

    Paige Fox, MD, PhD, FACS

    Associate Professor of Surgery (Plastic and Reconstructive Surgery)

    BioDr. Paige Fox is Board Certified Plastic Surgeon who specializes in hand surgery, reconstructive microsurgery including facial reanimation, as well as peripheral nerve and brachial plexus surgery. She is an Associate Professor in the Division of Plastic and Reconstructive surgery in the Department of Surgery. She works with adult and pediatric patients. Her lab focuses on wound healing and nerve compression. She has clinical research interested in optimizing care of upper extremity and nerve disorders both in the US and internationally. Dr. Fox has a passion for sustainability and health care's effect on the environment. She is involved in efforts to green the OR and the clinics at Stanford.

  • Christopher Francis

    Christopher Francis

    Professor of Earth System Science, of Oceans and Senior Fellow at the Woods Institute for the Environment

    Current Research and Scholarly InterestsMicrobial cycling of carbon, nitrogen, and metals in the environment; molecular geomicrobiology; marine microbiology; microbial diversity; meta-omics

  • Curtis Frank

    Curtis Frank

    W. M. Keck, Sr. Professor in Engineering, Emeritus

    BioThe properties of ultrathin polymer films are often different from their bulk counterparts. We use spin casting, Langmuir-Blodgett deposition, and surface grafting to fabricate ultrathin films in the range of 100 to 1000 Angstroms thick. Macromolecular amphiphiles are examined at the air-water interface by surface pressure, Brewster angle microscopy, and interfacial shear measurements and on solid substrates by atomic force microscopy, FTIR, and ellipsometry. A vapor-deposition-polymerization process has been developed for covalent grafting of poly(amino acids) from solid substrates. FTIR measurements permit study of secondary structures (right and left-handed alpha helices, parallel and anti-parallel beta sheets) as a function of temperature and environment.

    A broadly interdisciplinary collaboration has been established with the Department of Ophthalmology in the Stanford School of Medicine. We have designed and synthesized a fully interpenetrating network of two different hydrogel materials that have properties consistent with application as a substitute for the human cornea: high water swellability up to 85%,tensile strength comparable to the cornea, high glucose permeability comparable to the cornea, and sufficient tear strength to permit suturing. We have developed a technique for surface modification with adhesion peptides that allows binding of collagen and subsequent growth of epithelial cells. Broad questions on the relationships among molecular structure, processing protocol, and biomedical device application are being pursued.

  • Michael Frank

    Michael Frank

    Benjamin Scott Crocker Professor of Human Biology and Professor, by courtesy, of Linguistics

    Current Research and Scholarly InterestsHow do we learn to communicate using language? I study children's language learning and how it interacts with their developing understanding of the social world. I use behavioral experiments, computational tools, and novel measurement methods like large-scale web-based studies, eye-tracking, and head-mounted cameras.

  • Hunter Fraser

    Hunter Fraser

    Professor of Biology

    Current Research and Scholarly InterestsWe study the evolution of complex traits by developing new experimental and computational methods.

    Our work brings together quantitative genetics, genomics, epigenetics, and evolutionary biology to achieve a deeper understanding of how genetic variation shapes the phenotypic diversity of life. Our main focus is on the evolution of gene expression, which is the primary fuel for natural selection. Our long-term goal is to be able to introduce complex traits into new species via genome editing.

  • Michael Fredericson, MD

    Michael Fredericson, MD

    Professor of Orthopaedic Surgery and, by courtesy, of Medicine (Stanford Prevention Research Center)

    Current Research and Scholarly InterestsMy research focuses on the etiology, prevention, and treatment of overuse sports injuries in athletes and lifestyle medicine practices for improved health and longevity.

  • Michael T. Freehill, MD, FAOA

    Michael T. Freehill, MD, FAOA

    Associate Professor of Orthopaedic Surgery

    BioDr. Freehill is a board-certified, double fellowship-trained specialist in orthopaedic surgery with a sub-specialty certification in sports medicine and serves as Chief of Shoulder & Elbow Surgery. His concentration is in shoulder and sports elbow. Dr. Freehill serves as Head Team physician for the Athletics Major League Baseball organization. He is also a team physician for Stanford University athletics and Head Team physician for the Stanford University baseball.

    Dr. Freehill’s practice focuses on all shoulder conditions including rotator cuff tears, instability, arthritis, arthropathy, complex shoulder pathology, and sports related shoulder injury. In addition, he is also passionate about sports-related elbow injuries, with an emphasis on thrower’s elbow.

    Professional and amateur athletes, as well as non-athletes, come to Dr. Freehill for expert care. His sports medicine training and specialization in shoulder replacement procedures enable him to treat patients across the lifespan. Depending on factors including the patient’s condition and occupation, he may recommend treatment ranging from non-operative solutions (such as physical therapy), to cutting-edge biologics procedures, to complex surgery.

    Previously, he was a team physician for the Detroit Tigers and the Winston-Salem Dash (affiliated with the Chicago White Sox); he assisted with the Baltimore Orioles while in residency. He has also served as Director of Sports Medicine for Wake Forest University Athletics.

    As executive director of the Stanford Baseball Science CORE, Dr. Freehill draws on his previous experience as a professional baseball player to help athletes of all skill levels and push baseball science forward. He conducts cutting edge research on the biomechanics of overhead throwers and has studied pitch counts in adolescent players funded by Major League Baseball and is currently studying post-ulnar collateral ligament surgery in professional baseball hitters funded by the American Orthopaedic Society for Sports Medicine. (AOSSM). He is a member of the MLB Team Physicians Association and its Research Committee. Additionally, he was the pioneering mind behind the Pitching Lab at Wake Forest.

    Dr. Freehill has pioneered the use of some of the latest techniques and technology for leading-edge shoulder care. Among the advanced technologies he utilizes is a virtual reality (VR) planning software system that enables him to perform a simulated shoulder arthroplasty procedure prior to entering the operating room with a patient. He is also a member of the robotics team which will revolutionize the manner in which shoulder replacement is performed.

    Dr. Freehill has over 100 peer-reviewed articles and his work has been featured in the American Journal of Sports Medicine, Orthopedic Journal of Sports Medicine, Journal of Shoulder and Elbow Surgery, Arthroscopy, and elsewhere. He has written numerous book chapters and made over 400 presentations at regional, national, and international conferences. Dr. Freehill’s honors include the Orthopaedic Residency Research Award in residency at Johns Hopkins University. He is also a Neer Award winner, denoting the highest research award selected annually by the American Shoulder and Elbow Society and was awarded a research grant from the National Institutes of Health to investigate stromal vascular fractionated mesenchymal cells and their potential for healing rotator cuff tendon tears.

    Currently, the Associate Editor for Shoulder & Elbow for the American Journal of Sports Medicine, he is also a committee member for the American Shoulder and Elbow Surgeons Society, American Orthopaedic Society for Sports Medicine, International Congress of Arthroscopy and Sports Traumatology, Arthroscopy Association of North America, and American Academy of Orthopaedic Surgeons, American Orthopaedic Association and has been elected into the Herodicus Society.

  • Shai Friedland

    Shai Friedland

    Professor of Medicine (Gastroenterology and Hepatology)

    Current Research and Scholarly Interests1. Gastrointestinal Endoscopy- Techniques and Outcomes
    2. Noninvasive colorectal cancer screening
    3. Medical device development in gastroenterology

  • Anne L. Friedlander

    Anne L. Friedlander

    Adjunct Professor

    BioAnne L. Friedlander, Ph.D, is the Assistant Director of Stanford Lifestyle Medicine, an Adjunct Professor in the Program in Human Biology, and a member of the Wu Tsai Human Performance Alliance. She has served as the Director of the Exercise Physiology Lab, the Director of the Mobility Division within the Stanford Center on Longevity (SCL), and the Associate Director for Education within the Geriatric Research, Education and Clinical Center (GRECC) at the VA Palo Alto. Dr. Friedlander has broad research experience in the areas of enhancing human performance, environmental physiology, and using physical activity and mobility to promote healthy aging. She also consults regularly with companies interested in developing new products, programs and ideas in the fitness and wellness space. She is passionate about the benefits of movement on the aging process and specializes in giving talks translating scientific findings on physiology and exercise into practical applications for people.

  • Richard Frock

    Richard Frock

    Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)

    Current Research and Scholarly InterestsWe are a functional genomics laboratory interested in elucidating mechanisms of DNA repair pathway choice and genome instability. We use genome-wide repair fate maps of targeted DNA double strand breaks (DSBs) to develop pathway-specific models and combinatorial therapies. Our expertise overlaps many different fields including: genome editing, ionizing radiation, cancer therapeutics, V(D)J and IgH class switch recombination, repair during transcription and replication, and meiosis.

  • Victor Froelicher, MD

    Victor Froelicher, MD

    Professor of Medicine (Cardiovascular) at the Veterans Affairs Palo Alto Health Care System, Emeritus

    Current Research and Scholarly InterestsScreening of athletes for sudden cardiac death, Computerized ECG and clinical data management; exercise Physiology including expired gas analysis; the effect of chronic and acute exercise on the heart; digital recording of biological signals; diagnostic use of exercise testing; development of Expert Medical System software and educational tools.

  • Wolf B. Frommer

    Wolf B. Frommer

    Member, Bio-X

    Current Research and Scholarly InterestsWatching cells at work
    Focus: Transport / signaling across the plasma membrane (sugars, amino acids).
    Tools: FRET-based nanosensors for metabolite imaging (with subcellular resolution) in living organisms using confocal fluorescence microscopy and HTS; Sensor optimization by computational design; RNAi to modify cellular functions.
    Goals: Identify unknown sugar effluxers from liver/plant cells; study regulatory networks.
    Model systems: liver, neuronal, plant cell cultures, Arabidopsis, yeast

  • Judith Frydman

    Judith Frydman

    Donald Kennedy Chair in the School of Humanities and Sciences and Professor of Genetics

    Current Research and Scholarly InterestsThe long term goal of our research is to understand how proteins fold in living cells. My lab uses a multidisciplinary approach to address fundamental questions about molecular chaperones, protein folding and degradation. In addition to basic mechanistic principles, we aim to define how impairment of cellular folding and quality control are linked to disease, including cancer and neurodegenerative diseases and examine whether reengineering chaperone networks can provide therapeutic strategies.

  • Takako Fujioka

    Takako Fujioka

    Associate Professor of Music

    BioResearch topics include neural oscillations for auditory perception, auditory-motor coupling, brain plasticity in development and aging, and recovery from stroke with music-supported therapy.

    Her post-doctoral and research-associate work at Rotman Research Institute in Toronto was supported by awards from the Canadian Institutes of Health Research. Her research continues to explore the biological nature of human musical ability by examining brain activities with non-invasive human neurophysiological measures such as magnetoencephalography (MEG) and electroencephalography (EEG).

  • Francis Fukuyama

    Francis Fukuyama

    Olivier & Nomellini Senior Fellow in International Studies at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of Political Science

    Current Research and Scholarly InterestsDeveloping nations; governance; international political economy; nation-building and democratization; strategic and security issues

  • Gerald Fuller

    Gerald Fuller

    Fletcher Jones Professor in the School of Engineering

    BioThe processing of complex liquids (polymers, suspensions, emulsions, biological fluids) alters their microstructure through orientation and deformation of their constitutive elements. In the case of polymeric liquids, it is of interest to obtain in situ measurements of segmental orientation and optical methods have proven to be an excellent means of acquiring this information. Research in our laboratory has resulted in a number of techniques in optical rheometry such as high-speed polarimetry (birefringence and dichroism) and various microscopy methods (fluorescence, phase contrast, and atomic force microscopy).

    The microstructure of polymeric and other complex materials also cause them to have interesting physical properties and respond to different flow conditions in unusual manners. In our laboratory, we are equipped with instruments that are able to characterize these materials such as shear rheometer, capillary break up extensional rheometer, and 2D extensional rheometer. Then, the response of these materials to different flow conditions can be visualized and analyzed in detail using high speed imaging devices at up to 2,000 frames per second.

    There are numerous processes encountered in nature and industry where the deformation of fluid-fluid interfaces is of central importance. Examples from nature include deformation of the red blood cell in small capillaries, cell division and structure and composition of the tear film. Industrial applications include the processing of emulsions and foams, and the atomization of droplets in ink-jet printing. In our laboratory, fundamental research is in progress to understand the orientation and deformation of monolayers at the molecular level. These experiments employ state of the art optical methods such as polarization modulated dichroism, fluorescence microscopy, and Brewster angle microscopy to obtain in situ measurements of polymer films and small molecule amphiphile monolayers subject to flow. Langmuir troughs are used as the experimental platform so that the thermodynamic state of the monolayers can be systematically controlled. For the first time, well characterized, homogeneous surface flows have been developed, and real time measurements of molecular and microdomain orientation have been obtained. These microstructural experiments are complemented by measurements of the macroscopic, mechanical properties of the films.

  • Margaret T. Fuller

    Margaret T. Fuller

    Reed-Hodgson Professor of Human Biology, Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor of Genetics and of Obstetrics/Gynecology (Reproductive and Stem Cell Biology)

    Current Research and Scholarly InterestsRegulation of self-renewal, proliferation and differentiation in adult stem cell lineages. Developmental tumor suppressor mechanisms and regulation of the switch from proliferation to differentiation. Cell type specific transcription machinery and regulation of cell differentiation. Developmental regulation of cell cycle progression during male meiosis.

  • Lawrence Fung MD PhD

    Lawrence Fung MD PhD

    Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)

    Current Research and Scholarly InterestsDr. Lawrence Fung is a physician-scientist specializing in autism and neurodiversity. Dr. Fung is an associate professor of Psychiatry at Stanford University. He is the director of the Stanford Neurodiversity Project (SNP), director of the Neurodiversity Clinic, and PI at the Fung Lab. Dr. Fung’s research traverses from multi-modal neuroimaging studies to a new conceptualization of neurodiversity and its application to clinical, educational, and employment settings. His lab has two main arms of research: (1) neurobiology of autism and (2) neurodiversity.
    The neurobiology arm of his lab focuses on advancing the understanding of the thalamocortical circuits and their socio-communicative and cognitive functions in people on the spectrum by using novel neuroimaging and bioanalytical technologies. The findings of his neurobiology research efforts were published in top journals in our field, such as Molecular Psychiatry, Translational Psychiatry, and Psychoneuroendocrinology.
    Using a community-based participatory research approach, Dr. Fung’s team devises and implements novel interventions to improve the lives of neurodiverse individuals by maximizing their potential and productivity. He has developed and assessed several psychoeducational interventions, including the Developing Inclusive and Vocational Educational Resources for Success and Employment (DIVERSE) curriculum.
    Dr. Fung is also the founding director of the SNP, a special initiative of the Department of Psychiatry at Stanford. Since 2017, the SNP has organized various events, including the Stanford Neurodiversity Summit, which brings thousands of people together yearly to share visions, innovations, and inspirations about maximizing the potential of neurodiversity. Each summer, about 100 high-school students join us at the SNP’s Research, Education, and Advocacy Camp for High Schoolers (SNP-REACH), to learn how to develop neurodiversity advocacy projects. Dr. Fung also teaches a neurodiversity design thinking course at Stanford. Clinically, Dr. Fung has applied the SBMN to his clinical work and is teaching a CME course focusing on delivering neurodiversity-affirmative care to neurodivergent patients.

  • Ansgar Furst

    Ansgar Furst

    Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psychiatry and Behavioral Sciences

    BioDr. Furst is a Clinical Associate Professor (affiliated) of Psychiatry and Behavioral Sciences and of Neurology and Neurological Sciences at Stanford University School of Medicine. He is a Principal Investigator and Director of the California War Related Illness and Injury Study Center (WRIISC) Advanced Fellowship Post-Doctoral program and Associate Director of Neuroimaging. He is also a Senior Research Scientist at the Polytrauma System of Care (PSC) at VA Palo Alto Health Care System. Dr. Furst serves as Associate Editor for the journal Frontiers in Neurology and is a member of the editorial board of NEUROLOGY. His research focuses on chronic multisymptom illness, traumatic brain injury, sleep, pain and neurodegenerative diseases.

    For more information please visit:
    https://med.stanford.edu/furstlab.html

    Member of:
    Center for Sleep and Circadian Sciences
    https://med.stanford.edu/cscs.html

    Faculty Affiliate:
    Wu Tsai Human Performance Alliance
    https://humanperformance.stanford.edu

  • Kelly Gaffney

    Kelly Gaffney

    Professor of Photon Science and, by courtesy, of Chemistry

    Current Research and Scholarly InterestsThe research team Professor Gaffney leads focuses on time resolved studies of chemical reactions. Recent advances in ultrafast x-ray lasers, like the LCLS at SLAC National Accelerator Laboratory, enable chemical reactions to be observed on the natural time and length scales of the chemical bond – femtoseconds and Ångströms. The knowledge gained from x-ray and optical laser studies will be used to spark new approaches to photo-catalysis and chemical synthesis.

  • Stephen J. Galli, MD

    Stephen J. Galli, MD

    Mary Hewitt Loveless, MD, Professor in the School of Medicine and Professor of Pathology and of Microbiology and Immunology

    Current Research and Scholarly InterestsThe goals of Dr. Galli's laboratory are to understand the regulation of mast cell and basophil development and function, and to develop and use genetic approaches to elucidate the roles of these cells in health and disease. We study both the roles of mast cells, basophils, and IgE in normal physiology and host defense, e.g., in responses to parasites and in enhancing resistance to venoms, and also their roles in pathology, e.g., anaphylaxis, food allergy, and asthma, both in mice and humans.

  • Sanjiv Sam Gambhir, MD, PhD

    Sanjiv Sam Gambhir, MD, PhD

    Member, Bio-X

    Current Research and Scholarly InterestsMy laboratory focuses on merging advances in molecular biology with those in biomedical imaging to advance the field of molecular imaging. Imaging for the purpose of better understanding cancer biology and applications in gene and cell therapy, as well as immunotherapy are all being studied. A key long-term focus is the earlier detection of cancer by combining in vitro diagnostics and molecular imaging.

  • Alex Gao

    Alex Gao

    Assistant Professor of Biochemistry and of Microbiology and Immunology

    Current Research and Scholarly InterestsWe integrate computational genome mining with high-throughput experimental approaches and structural biology to harness the rich diversity of genes from microbes, with the goal of developing new antibiotic strategies and molecular biotechnology. A major area of current interest is uncovering novel molecular functions involved in anti-phage defense and bacteria–phage interactions, which are a major driver of molecular innovation in nature.

  • Xiaojing Gao

    Xiaojing Gao

    Assistant Professor of Chemical Engineering

    Current Research and Scholarly InterestsHow do we design biological systems as “smart medicine” that sense patients’ states, process the information, and respond accordingly? To realize this vision, we will tackle fundamental challenges across different levels of complexity, such as (1) protein components that minimize their crosstalk with human cells and immunogenicity, (2) biomolecular circuits that function robustly in different cells and are easy to deliver, (3) multicellular consortia that communicate through scalable channels, and (4) therapeutic modules that interface with physiological inputs/outputs. Our engineering targets include biomolecules, molecular circuits, viruses, and cells, and our approach combines quantitative experimental analysis with computational simulation. The molecular tools we build will be applied to diverse fields such as neurobiology and cancer therapy.

  • Alan M. Garber

    Alan M. Garber

    Henry J. Kaiser Jr. Professor and Professor of Medicine, Emeritus

    Current Research and Scholarly InterestsTopics in the health economics of aging; health, insurance; optimal screening intervals; cost-effectiveness of, coronary surgery in the elderly; health care financing and delivery, in the United States and Japan; coronary heart disease

  • Chris Garcia

    Chris Garcia

    Younger Family Professor and Professor of Structural Biology

    Current Research and Scholarly InterestsStructural and functional studies of transmembrane receptor interactions with their ligands in systems relevant to human health and disease - primarily in immunity, infection, and neurobiology. We study these problems using protein engineering, structural, biochemical, and combinatorial biology approaches.

  • Christopher Gardner

    Christopher Gardner

    Rehnborg Farquhar Professor

    Current Research and Scholarly InterestsThe role of nutrition in individual and societal health, with particular interests in: plant-based diets, differential response to low-carb vs. low-fat weight loss diets by insulin resistance status, chronic disease prevention, randomized controlled trials, human nutrition, community based studies, Community Based Participatory Research, sustainable food movement (animal rights and welfare, global warming, human labor practices), stealth health, nutrition policy, nutrition guidelines

  • Justin Gardner

    Justin Gardner

    Associate Professor of Psychology

    Current Research and Scholarly InterestsHow does neural activity in the human cortex create our sense of visual perception? We use a combination of functional magnetic resonance imaging, computational modeling and analysis, and psychophysical measurements to link human perception to cortical brain activity.

  • Joseph Garner

    Joseph Garner

    Professor of Comparative Medicine and, by courtesy, of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsThe medical research community has long recognized that "good well-being is good science". The lab uses an integrated interdisciplinary approach to explore this interface, while providing tangible deliverables for the well-being of human patients and research animals.

  • Matthias Garten

    Matthias Garten

    Assistant Professor of Microbiology and Immunology and of Bioengineering

    Current Research and Scholarly InterestsWith a creative, collaborative, biophysical mindset, we aim to understand the ability non-model organisms to interface with environment to a point at which we can exploit the mechanisms finding cures against diseases and use the mechanisms as tools that we can use to engineer the environment. By developing approaches that allow a quantitative understanding and manipulation of molecular transport our research makes non-model organisms accessible to researchers and engineers.

    Specifically, we are studying how the malaria parasite takes control over red blood cells. By learning the biophysical principles of transport in between the host and the parasite we can design ways to kill the parasite or exploit it to reengineer red blood cells. The transport we study is broadly encompassing everything from ions to lipids and proteins. We use variations of quantitative microscopy and electrophysiology to gain insight into the unique strategies the parasite evolved to survive.

  • Sergios Gatidis

    Sergios Gatidis

    Associate Professor of Radiology (Pediatric Radiology)

    BioDr. Gatidis completed his medical training at the University of Tuebingen / Germany and received his Diploma in Mathematics from from the Universities of Tuebingen and Hagen / Germany. His research is focused on on methods and applications of machine learning for medical data analysis and translation of AI into clinical practice.

  • Brice Gaudilliere

    Brice Gaudilliere

    Professor of Anesthesiology, Perioperative and Pain Medicine (MSD) and, by courtesy, of Pediatrics (Neonatology)

    Current Research and Scholarly InterestsThe advent of high dimensional flow cytometry has revolutionized our ability to study and visualize the human immune system. Our group combines high parameter mass cytometry (a.k.a Cytometry by Time of Flight Mass Spectrometry, CyTOF), with advanced bio-computational methods to study how the human immune system responds and adapts to acute physiological perturbations. The laboratory currently focuses on two clinical scenarios: surgical trauma and pregnancy.

  • Charles Gawad

    Charles Gawad

    Associate Professor of Pediatrics (Hematology/Oncology)
    On Partial Leave from 02/01/2025 To 03/29/2026

    BioOur lab works at the interface of biotechnology, computational biology, cellular biology, and clinical medicine to develop and apply new tools for characterizing genetic variation across single cells within a tissue with unparalleled sensitivity and accuracy. We are focused on applying these technologies to study cancer clonal evolution while patients are undergoing treatment with the aim of identifying cancer clonotypes that are associated with resistance to specific drugs so as to better understand and predict treatment response. We are also applying these methods to understand how more virulent pathogens emerge from a population of bacteria or viruses with an emphasis on developing a deeper understanding of how antibiotic resistance develops.

  • Pascal Geldsetzer

    Pascal Geldsetzer

    Assistant Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health

    BioPascal Geldsetzer is an Assistant Professor of Medicine in the Division of Primary Care and Population Health and, by courtesy, in the Department of Epidemiology and Population Health. He is also affiliated with the Phil & Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, Department of Biomedical Data Science, Department of Health Policy, and the Stanford Center for Population Health Sciences.

    His research focuses on identifying and evaluating the most effective interventions for improving health at older ages. In addition to leading several randomized trials, his methodological emphasis lies on the use of natural experiments to ascertain causal effects in large observational datasets, particularly in electronic health record data. He has won an NIH New Innovator Award (in 2022), a Chan Zuckerberg Biohub investigatorship (in 2022), and three NIH R01 grants as Principal Investigator (in 2023 and 2024). In 2026, he was named one of the 100 most influential people in health and medicine globally by TIME Magazine.

  • Michael Genesereth

    Michael Genesereth

    Associate Professor of Computer Science

    BioGenesereth is most known for his work on Computational Logic and applications of that work in Enterprise Management, Computational Law, and General Game Playing. He is one of the founders of Teknowledge, CommerceNet, Mergent Systems, and Symbium. Genesereth is the director of the Logic Group at Stanford and the founder and research director of CodeX - the Stanford Center for Legal Informatics.

  • Grace Gengoux, PhD, BCBA-D

    Grace Gengoux, PhD, BCBA-D

    Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    Current Research and Scholarly InterestsDr. Grace Gengoux is Director of the Autism Intervention Clinic and leads an autism intervention research program focused on developing and evaluating promising behavioral and developmental treatments for Autism Spectrum Disorder (ASD).

    Dr. Gengoux is also Associate Chair for Faculty Engagement & Well-being and Department Well-being Director in the Department of Psychiatry and Behavioral Sciences, leading the department's Standing Well-being Advisory Committee.

  • Michael Gensheimer

    Michael Gensheimer

    Clinical Associate Professor, Radiation Oncology - Radiation Therapy

    Current Research and Scholarly InterestsIn addition to my clinical research in head and neck and lung cancer, I work on the application of computer science and machine learning to cancer research. I develop tools for analyzing large datasets to improve outcomes and safety of cancer treatment. I developed a machine learning prognostic model using data from around 13,000 patients with metastatic cancer which performs better than traditional models and physicians [PubMed ID 33313792]. We recently completed a prospective randomized study in thousands of patients in which the model was used to help improve advance care planning conversations.

    I also work on the methods underpinning observational and predictive modeling research. My open source nnet-survival software that allows use of neural networks for survival modeling has been used by researchers internationally. In collaboration with the Stanford Research Informatics Center, I examined how electronic medical record (EMR) survival outcome data compares to gold-standard data from a cancer registry [PubMed ID 35802836]. The EMR data captured less than 50% of deaths, a finding that affects many studies being published that use EMR outcomes data.

  • Paul George, MD, PhD

    Paul George, MD, PhD

    Associate Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsCONDUCTIVE POLYMER SCAFFOLDS FOR STEM CELL-ENHANCED STROKE RECOVERY:
    We focus on developing conductive polymers for stem cell applications. We have created a microfabricated, polymeric system that can continuously interact with its biological environment. This interactive polymer platform allows modifications of the recovery environment to determine essential repair mechanisms. Recent work studies the effect of electrical stimulation on neural stem cells seeded on the conductive scaffold and the pathways by which it enhances stroke recovery Further understanding the combined effect of electrical stimulation and stem cells in augmenting neural repair for clinical translational is a major focus of this research going forward.

    BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
    The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for stroke and neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration and stroke recovery. Recent work utilizing these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.

    APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
    The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes.

  • Margot Gerritsen

    Margot Gerritsen

    Professor of Energy Resources Engineering, Emerita

    Current Research and Scholarly InterestsResearch
    My work is about understanding and simulating complicated fluid flow problems. My research focuses on the design of highly accurate and efficient parallel computational methods to predict the performance of enhanced oil recovery methods. I'm particularly interested in gas injection and in-situ combustion processes. These recovery methods are extremely challenging to simulate because of the very strong nonlinearities in the governing equations. Outside petroleum engineering, I'm active in coastal ocean simulation with colleagues from the Department of Civil and Environmental Engineering, yacht research and pterosaur flight mechanics with colleagues from the Department of Mechanical and Aeronautical Engineering, and the design of search algorithms in collaboration with the Library of Congress and colleagues from the Institute of Computational and Mathematical Engineering.

    Teaching
    I teach courses in both energy related topics (reservoir simulation, energy, and the environment) in my department, and mathematics for engineers through the Institute of Computational and Mathematical Engineering (ICME). I also initiated two courses in professional development in our department (presentation skills and teaching assistant training), and a consulting course for graduate students in ICME, which offers expertise in computational methods to the Stanford community and selected industries.

    Professional Activities
    Senior Associate Dean, School of Earth, Energy and Environmental Sciences, Stanford (from 2015); Director, Institute for Computational and Mathematical Engineering, Stanford (from 2010); Stanford Fellow (2010-2012); Magne Espedal Professor II, Bergen University (2011-2014); Aldo Leopold Fellow (2009); Chair, SIAM Activity group in Geosciences (2007, present, reelected in 2009); Faculty Research Fellow, Clayman Institute (2008); Elected to Council of Society of Industrial and Applied Mathematics (SIAM) (2007); organizing committee, 2008 Gordon Conference on Flow in Porous Media; producer, Smart Energy podcast channel; Director, Stanford Yacht Research; Co-director and founder, Stanford Center of Excellence for Computational Algorithms in Digital Stewardship; Editor, Journal of Small Craft Technology; Associate editor, Transport in Porous Media; Reviewer for various journals and organizations including SPE, DoE, NSF, Journal of Computational Physics, Journal of Scientific Computing, Transport in Porous Media, Computational Geosciences; member, SIAM, SPE, KIVI, AGU, and APS

  • Olivier Gevaert

    Olivier Gevaert

    Associate Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science

    Current Research and Scholarly InterestsMy lab focuses on biomedical data fusion: the development of machine learning methods for biomedical decision support using multi-scale biomedical data. We primarily use methods based on regularized linear regression to accomplish this. We primarily focus on applications in oncology and neuroscience.

  • Amato J. Giaccia

    Amato J. Giaccia

    Jack, Lulu and Sam Willson Professor, Professor of Radiation Oncology, Emeritus

    Current Research and Scholarly InterestsDuring the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically.

  • William Giardino

    William Giardino

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)

    Current Research and Scholarly InterestsWe aim to decipher the neural mechanisms underlying psychiatric conditions of stress, addiction, and sleep/circadian dysregulation. Our work uses combinatorial technologies for precisely mapping, monitoring, and manipulating neural circuits that regulate emotional states. We are especially focused on the behavioral functions of neuropeptide molecules acting throughout the circuitry of the extended amygdala- particularly in a brain region called the bed nucleus of the stria terminalis (BNST).

  • Erin Gibson

    Erin Gibson

    Assistant Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)

    Current Research and Scholarly InterestsGlia make up more than half of the cells in the human brain, but we are just beginning to understand the complex and multifactorial role glia play in health and disease. Glia are decidedly dynamic in form and function. Understanding the mechanisms underlying this dynamic nature of glia is imperative to developing novel therapeutic strategies for diseases of the nervous system that involve aberrant gliogenesis, especially related to changes in myelination.

  • Rona Giffard

    Rona Giffard

    Professor of Anesthesiology, Perioperative and Pain Medicine, Emerita

    Current Research and Scholarly InterestsAstrocytes, microglia and neurons interact, and have unique vulnerabilities to injury based on their patterns of gene expression and their functional roles. We focus on the cellular and molecular basis of brain cell injury in stroke. We study the effects of altering miRNA expression, altering levels of heat shock and cell death regulatory proteins. Our goal is to improve outcome by improving mitochondrial function and brain cell survival, and reducing oxidative stress and inflammation.

  • William Gilly

    William Gilly

    Professor of Oceans
    On Leave from 01/01/2026 To 03/31/2026

    Current Research and Scholarly InterestsMy work has contributed to understanding electrical excitability in nerve & muscle in organisms ranging from brittle-stars to mammals. Current research addresses behavior, physiology and ecology of squid through field and lab approaches. Electronic tagging plus in situ video, acoustic and oceanographic methods are used to study behaviors and life history in the field. Lab work focuses on control of chromogenic behavior by the chromatophore network and of locomotion by the giant axon system.

  • Lisa Giocomo

    Lisa Giocomo

    Professor of Neurobiology

    Current Research and Scholarly InterestsMy laboratory studies the cellular and molecular mechanisms underlying the organization of cortical circuits important for spatial navigation and memory. We are particularly focused on medial entorhinal cortex, where many neurons fire in spatially specific patterns and thus offer a measurable output for molecular manipulations. We combine electrophysiology, genetic approaches and behavioral paradigms to unravel the mechanisms and behavioral relevance of non-sensory cortical organization. Our first line of research is focused on determining the cellular and molecular components crucial to the neural representation of external space by functionally defined cell types in entorhinal cortex (grid, border and head direction cells). We plan to use specific targeting of ion channels, combined with in vivo tetrode recordings, to determine how channel dynamics influence the neural representation of space in the behaving animal. A second, parallel line of research, utilizes a combination of in vivo and in vitro methods to further parse out ionic expression patterns in entorhinal cortices and determine how gradients in ion channels develop. Ultimately, our work aims to understand the ontogenesis and relevance of medial entorhinal cortical topography in spatial memory and navigation.

  • Nicholas Giori MD, PhD

    Nicholas Giori MD, PhD

    Professor of Orthopaedic Surgery

    Current Research and Scholarly InterestsOsteoarthritis
    Medical Device Development

  • Aaron D. Gitler

    Aaron D. Gitler

    Stanford Medicine Basic Science Professor

    Current Research and Scholarly InterestsWe investigate the mechanisms of human neurodegenerative diseases, including Alzheimer disease, Parkinson disease, and ALS. We don't limit ourselves to one model system or experimental approach. We start with yeast, perform genetic and chemical screens, and then move to other model systems (e.g. mammalian tissue culture, mouse, fly) and even work with human patient samples (tissue sections, patient-derived cells, including iPS cells) and next generation sequencing approaches.

  • Linda Giudice

    Linda Giudice

    Stanley McCormick Memorial Professor in the School of Medicine, Emerita

    Current Research and Scholarly InterestsOur research is in reproductive endocrinology and reproductive genomics. It focuses on human endometrial biology as it relates to basic biological mechanisms underlying steroid hormone action in this tissue, normal and abnormal placenta-decidua interactions, mechanisms underlying placentation and abnormal fetal growth, endometrial stem cells, and functional genomics for diagnostics and therapeutics of endometrial disorders. We also study mechanisms underlying ovarian follicle steroidogenesis.

  • Jeffrey S.  Glenn, M.D., Ph.D.

    Jeffrey S. Glenn, M.D., Ph.D.

    Joseph D. Grant Professor and Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsDr. Glenn's primary interest is in molecular virology, with a strong emphasis on translating this knowledge into novel antiviral therapies. Other interests include exploitation of hepatic stem cells, engineered human liver tissues, liver cancer, and new biodefense antiviral strategies.

  • Siegfried Glenzer

    Siegfried Glenzer

    Professor of Photon Science and, by courtesy, of Mechanical Engineering

    Current Research and Scholarly InterestsPlease see our website for detailed information: https://heds.slac.stanford.edu

  • Gary Glover

    Gary Glover

    Professor of Radiology (Radiological Sciences Lab) and, by courtesy, of Psychology and of Electrical Engineering

    Current Research and Scholarly InterestsMy present research is devoted to the advancement of functional magnetic resonance imaging sciences for applications in basic understanding of the brain in health and disease. We collaborate closely with departmental clinicians and with others in the school of medicine, humanities, and the engineering sciences.

  • Anna L Gloyn

    Anna L Gloyn

    Professor of Pediatrics (Endocrinology) and of Genetics

    Current Research and Scholarly InterestsAnna's current research projects are focused on the translation of genetic association signals for type 2 diabetes and glycaemic traits into cellular and molecular mechanisms for beta-cell dysfunction and diabetes. Her group uses a variety of complementary approaches, including human genetics, functional genomics, physiology and islet-biology to dissect out the molecular mechanisms driving disease pathogenesis.

  • Ashish Goel

    Ashish Goel

    Stanford W. Ascherman, MD Professor in the School of Engineering and Professor, by courtesy, of Computer Science

    BioAshish Goel is a Professor of Management Science and Engineering, the Fortinet Founders Chair of Management Science and Engineering, and Professor (by courtesy) of Computer Science at Stanford University. He received his PhD in Computer Science from Stanford in 1999, and was an Assistant Professor of Computer Science at the University of Southern California from 1999 to 2002. His research interests lie in the design, analysis, and applications of algorithms.

  • Lauren Goins

    Lauren Goins

    Assistant Professor of Developmental Biology

    Current Research and Scholarly InterestsThe Goins lab aims to understand how cells make decisions. Our research focuses on how young, immature blood stem cells, with the potential to become many different cell types, choose between these cell fates.

  • Garry Gold

    Garry Gold

    Stanford Medicine Professor of Radiology and Biomedical Imaging
    On Leave from 02/16/2026

    Current Research and Scholarly InterestsMy primary focus is application of new MR imaging technology to musculoskeletal problems. Current projects include: Rapid MRI for Osteoarthritis, Weight-bearing cartilage imaging with MRI, and MRI-based models of muscle. We are studying the application of new MR imaging techniques such as rapid imaging, real-time imaging, and short echo time imaging to learn more about biomechanics and pathology of bones and joints. I am also interested in functional imaging approaches using PET-MRI.

  • Jeffrey Goldberg, MD, PhD

    Jeffrey Goldberg, MD, PhD

    Blumenkranz Smead Professor

    Current Research and Scholarly InterestsLab research on molecular mechanisms of survival and regeneration in the visual system; retinal development and stem cell biology; nanoparticles and tissue engineering. Clinical trials in imaging, biomarker development, and neuroprotection and vision restoration in glaucoma and other neurodegenerative diseases.

  • Jeremy Goldbogen

    Jeremy Goldbogen

    Associate Professor of Oceans

    BioJeremy Goldbogen is an Associate Professor of Oceans at Stanford University, based at the Hopkins Marine Station in Pacific Grove, California. He is a comparative physiologist who studies the integrative biology of marine organisms, with a particular focus on the feeding biomechanics, energetics, and foraging ecology of baleen whales.

    Goldbogen received his B.S. in Zoology from the University of Texas at Austin, where he began his research career studying the biomechanics of locomotion in hummingbirds and Antarctic pteropods. He earned his M.S. in Marine Biology from Scripps Institution of Oceanography and his Ph.D. in Zoology from the University of British Columbia, where his dissertation on the mechanics and energetics of rorqual lunge feeding earned him the Governor General's Gold Medal—UBC's most outstanding PhD award. Following postdoctoral positions at Scripps and the Cascadia Research Collective, he joined Stanford's faculty in 2014.

    His research program uses cutting-edge bio-logging technology—animal-attached sensors including accelerometers, video cameras, and echosounders—to study the behavior and physiology of marine megafauna in their natural environment. His lab has made groundbreaking discoveries about whale feeding mechanics, cardiovascular function, and the ecological consequences of body size in cetaceans. Notable achievements include the first recordings of a blue whale's heart rate and insights into why whales are big but not bigger.

  • Jeremy Goldhaber-Fiebert

    Jeremy Goldhaber-Fiebert

    Professor of Health Policy

    BioJeremy Goldhaber-Fiebert, PhD, is a Professor of Health Policy and a Core Faculty Member in the Centers for Health Policy and Primary Care and Outcomes Research. His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, and hepatitis C and on risk factors including smoking, physical activity, obesity, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues. Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011 and Secretary/Treasurer in 2021.

    Past and current research topics:

    - Type 2 diabetes and cardiovascular risk factors: Randomized and observational studies in Costa Rica examining the impact of community-based lifestyle interventions and the relationship of gender, risk factors, and care utilization.

    -Cervical cancer: Model-based cost-effectiveness analyses and costing methods studies that examine policy issues relating to cervical cancer screening and human papillomavirus vaccination in countries including the United States, Brazil, India, Kenya, Peru, South Africa, Tanzania, and Thailand.

    - Measles, haemophilus influenzae type b, and other childhood infectious diseases: Longitudinal regression analyses of country-level data from middle and upper income countries that examine the link between vaccination, sustained reductions in mortality, and evidence of herd immunity.

    - Patient adherence: Studies in both developing and developed countries of the costs and effectiveness of measures to increase successful adherence. Adherence to cervical cancer screening as well as to disease management programs targeting depression and obesity is examined from both a decision-analytic and a behavioral economics perspective.

    - Simulation modeling methods: Research examining model calibration and validation, the appropriate representation of uncertainty in projected outcomes, the use of models to examine plausible counterfactuals at the biological and epidemiological level, and the reflection of population and spatial heterogeneity.

  • David Goldhaber-Gordon

    David Goldhaber-Gordon

    TG Wijaya Professor of Physics and Professor, by courtesy, of Applied Physics

    Current Research and Scholarly InterestsHow do electrons organize themselves on the nanoscale?

    We know that electrons are charged particles, and hence repel each other; yet in common metals like copper billions of electrons have plenty of room to maneuver and seem to move independently, taking no notice of each other. Professor Goldhaber-Gordon studies how electrons behave when they are instead confined to tiny structures, such as wires only tens of atoms wide. When constrained this way, electrons cannot easily avoid each other, and interactions strongly affect their organization and flow. The Goldhaber-Gordon group uses advanced fabrication techniques to confine electrons to semiconductor nanostructures, to extend our understanding of quantum mechanics to interacting particles, and to provide the basic science that will shape possible designs for future transistors and energy conversion technologies. The Goldhaber-Gordon group makes measurements using cryogenics, precision electrical measurements, and novel scanning probe techniques that allow direct spatial mapping of electron organization and flow. For some of their measurements of exotic quantum states, they cool electrons to a fiftieth of a degree above absolute zero, the world record for electrons in semiconductor nanostructures.

  • Andrea Goldsmith

    Andrea Goldsmith

    Stephen Harris Professor in the School of Engineering, Emerita

    BioAndrea Goldsmith is the Dean of Engineering and Applied Science and the Arthur LeGrand Doty Professor of Electrical and Computer Engineering at Princeton University. She was previously the Stephen Harris Professor of Engineering and Professor of Electrical Engineering at Stanford University, where she is now Harris Professor Emerita. Her research interests are in information theory, communication theory, and signal processing, and their application to wireless communications, interconnected systems, and biomedical devices. She founded and served as Chief Technical Officer of Plume WiFi (formerly Accelera, Inc.) and of Quantenna (QTNA), Inc, and she serves on the Board of Directors for Intel (INTC), Medtronic (MDT), Crown Castle Inc (CCI), and the Marconi Society. She also serves on the Presidential Council of Advisors on Science and Technology (PCAST). Dr. Goldsmith is a member of the National Academy of Engineering, the Royal Academy of Engineering, and the American Academy of Arts and Sciences. She is a Fellow of the IEEE and has received several awards for her work, including the Marconi Prize, the ACM Sigmobile Outstanding Contribution Award, the IEEE Sumner Technical Field Award, the ACM Athena Lecturer Award, the ComSoc Armstrong Technical Achievement Award, the Kirchmayer Graduate Teaching Award, the WICE Mentoring Award, and the Silicon Valley/San Jose Business Journal’s Women of Influence Award. She is author of the book ``Wireless Communications'' and co-author of the books ``MIMO Wireless Communications,” “Principles of Cognitive Radio,” and “Machine Learning and Wireless Communications,” all published by Cambridge University Press, as well as an inventor on 29 patents. She received the B.S., M.S. and Ph.D. degrees in Electrical Engineering from U.C. Berkeley.

    Dr. Goldsmith is the founding Chair of the IEEE Board of Directors Committee on Diversity and Inclusion. She served as President of the IEEE Information Theory Society in 2009, as founding Chair of its Student Committee, and as founding Editor-in-Chief of the IEEE Journal on Selected Areas in Information Theory. She has also served on the Board of Governors for both the IEEE Information Theory and Communications Societies. At Stanford she served as Chair of Stanford’s Faculty Senate and for multiple terms as a Senator, and on its Academic Council Advisory Board, Budget Group, Committee on Research, Planning and Policy Board, Commissions on Graduate and on Undergraduate Education, Faculty Women’s Forum Steering Committee, and Task Force on Women and Leadership.

  • Judith L. Goldstein

    Judith L. Goldstein

    Janet M. Peck Professor of International Communication, Professor of Political Science and Senior Fellow at the Stanford Institute for Economic Policy Research

    BioJudith L. Goldstein is the Janet M. Peck Professor of International Communication and the Kaye University Fellow in Undergraduate Education. Her research focuses on international political economy, with a focus on trade politics. She has written and/or edited six book including Ideas, Interests and American Trade Policy and more recently The Evolution of the Trade Regime: Politics, Law and Economics of the GATT and the WTO. Her articles have appeared in numerous journals.

    Her current research focuses on the political requisites for trade liberalization focusing both on tariff bargaining and public preferences. As well, she is engaged in the analysis of a large survey panel, which focuses on how economic hard times influences public opinion.

    Goldstein has a BA from the University of California Berkeley, a Masters degree from Columbia University and a Ph.D. from UCLA.

  • Mary Kane Goldstein

    Mary Kane Goldstein

    Professor of Health Policy, Emerita

    Current Research and Scholarly InterestsHealth services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support (CDS) integrated with electronic health records; encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records; analyzing multiple comorbidities

  • Andrea Goldstein-Piekarski

    Andrea Goldstein-Piekarski

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)

    BioDr. Goldstein-Piekarski directs the Computational Psychiatry, Neuroscience, and Sleep Laboratory (CoPsyN Sleep Lab) as an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and PI within the Sierra-Pacific Mental Illness Research, Education and Clinical Center (MIRECC) at the Palo Alto VA. She received her PhD in 2014 at the University of California, Berkeley where she studied the consequences of sleep on emotional brain function. She then completed a Postdoctoral fellowship at Stanford focusing on understanding the brain basis of anxiety and depression.

    As the director of the CoPsyN Sleep Lab she is developing a translational, interdisciplinary research program that combines human neuroimaging, high-density EEG sleep recording, and computational modeling to understand the neural mechanisms through which sleep disruption contributes to affective disorders, particularly depression, across the lifespan. The ultimate goals of this research are to (1) develop mechanistically-informed interventions that directly target aspects of sleep and brain function to prevent and treat affective disorders and (2) identify novel biomarkers which can identify which individuals are most likely to experience improved mood following targeted sleep interventions.

    This work is currently supported by The KLS Foundation, a R01 from National Institute of Mental Health, and a R61 from the National Institute of Mental Health.

  • Natalia Gomez-Ospina

    Natalia Gomez-Ospina

    Assistant Professor of Pediatrics (Genetics)

    Current Research and Scholarly InterestsDr. Gomez-Ospina is a physician scientist and medical geneticist with a strong interest in the diagnosis and management of genetic diseases.

    1) Lysosomal storage diseases:
    Her research program is on developing better therapies for a large class of neurodegenerative diseases in children known as lysosomal storage disorders. Her current focus is on developing genome editing of hematopoietic stem cells as a therapeutic approach for these diseases beginning with Mucopolysaccharidosis type 1 and Gaucher disease. She established a genetic approach where therapeutic proteins can be targeted to a single well-characterized place in the genome known as a safe harbor. This approach constitutes a flexible, “one size fits all” approach that is independent of specific genes and mutations. This strategy, in which the hematopoietic system is commandeered to express and deliver therapeutic proteins to the brain can potentially change the current approaches to treating childhood neurodegenerative diseases and pave the way for alternative therapies for adult neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease


    2) Point of care ammonia testing
    She also works in collaboration with other researchers at Stanford to develop point-of-care testing for serum ammonia levels. Such device will greatly improve the quality of life of children and families with metabolic disorders with hyperammonemia.

    3) Gene discovery
    Dr Gomez-Ospina lead a multi-institutional collaboration resulting in the discovery of a novel genetic cause of neonatal and infantile cholestatic liver disease. She collaborated in the description of two novel neurologic syndromes caused by mutations in DYRK1 and CHD4.


    For more information go to our website:

    https://www.gomezospina.com/

  • Alexander Gonzalez

    Alexander Gonzalez

    Scientific Project Manager

    Current Role at StanfordScientific Project Manager for the Wu Tsai Human Performance Alliance

  • Benjamin Good

    Benjamin Good

    Assistant Professor of Applied Physics and, by courtesy, of Biology

    BioBenjamin Good is a theoretical biophysicist with a background in experimental evolution and population genetics. He is interested in the short-term evolutionary dynamics that emerge in rapidly evolving microbial populations like the gut microbiome. Technological advances are revolutionizing our ability to peer into these evolving ecosystems, providing us with an increasingly detailed catalog of their component species, genes, and pathways. Yet a vast gap still remains in understanding the population-level processes that control their emergent structure and function. Our group uses tools from statistical physics, population genetics, and computational biology to understand how microscopic growth processes and genome dynamics at the single cell level give rise to the collective behaviors that can be observed at the population level. Projects range from basic theoretical investigations of non-equilibrium processes in microbial evolution and ecology, to the development of new computational tools for measuring these processes in situ in both natural and experimental microbial communities. Through these specific examples, we seek to uncover unifying theoretical principles that could help us understand, forecast, and eventually control the ecological and evolutionary dynamics that take place in these diverse scenarios.

  • Zinaida Good, Ph.D.

    Zinaida Good, Ph.D.

    Assistant Professor of Medicine (Immunology and Rheumatology)

    Current Research and Scholarly InterestsOur laboratory integrates cutting-edge synthetic biology, immunology, and machine learning to engineer T cell therapies for cancer and autoimmune diseases. We have 3 research areas:
    - Analysis of clinical single-cell and spatial transcriptomics datasets from T cell therapy trials to identify mechanisms of resistance
    - Building AI systems to generate T cell designs predicted to improve patient outcomes
    - Genetic screens of novel T cell designs in models that mimic key mechanisms of resistance

  • Miriam B. Goodman

    Miriam B. Goodman

    Mrs. George A. Winzer Professor of Cell Biology

    Current Research and Scholarly InterestsWe study the molecular events that give rise to the sensation of touch and chemical stressors that compromise touch sensation in C. elegans. To do this, we use a combination of quantitative behavioral analysis, genetics, in vivo electrophysiology, and heterologous expression of ion channels. We collaborate with physicists and other physiologist to expand our experimental research.

  • Stuart Goodman, MD, PhD

    Stuart Goodman, MD, PhD

    The Robert L. and Mary Ellenburg Professor of Surgery and Professor, by courtesy, of Bioengineering

    Current Research and Scholarly InterestsAs an academic orthopaedic surgeon, my interests center on adult reconstructive surgery, arthritis surgery, joint replacement, biomaterials, biocompatibility, tissue engineering, mesenchymal stem cells. Collaborative clinical, applied and basic research studies are ongoing.

  • Kenneth Goodson

    Kenneth Goodson

    Vice Provost for Graduate Education and Postdoctoral Affairs, Davies Family Provostial Professor, and Professor, by courtesy, of Materials Science and Engineering

    Current Research and Scholarly InterestsProf. Goodson’s Nanoheat Lab studies heat transfer in electronic nanostructures, microfluidic heat sinks, and packaging, focussing on basic transport physics and practical impact for industry. We work closely with companies on novel cooling and packaging strategies for power devices, portables, ASICs, & data centers. At present, sponsors and collaborators include ARPA-E, the NSF POETS Center, SRC ASCENT, Google, Intel, Toyota, Ford, among others.

  • William Rowland Goodyer, MD/PhD

    William Rowland Goodyer, MD/PhD

    Assistant Professor of Pediatrics (Cardiology)

    BioDr. Goodyer is a physician scientist who specializes in Pediatric Cardiology and Electrophysiology. Will graduated from McGill University (Montreal, Canada) with a BSc in Biology prior to completing his graduate studies at Stanford University in the Medical Scientist Training Program (MSTP). He subsequently completed residency training in Pediatrics at Boston Children’s Hospital before returning to Stanford to complete a fellowship in Pediatric Cardiology and advanced fellowship in Pediatric Electrophysiology. He additionally performed a postdoctoral fellowship in the Sean Wu laboratory at the Stanford Cardiovascular Institute where he developed the first comprehensive single-cell gene atlas of the entire murine cardiac conduction system (CCS) as well as pioneered the generation of optical imaging agents for the real-time visualization of the CCS to help prevent accidental surgical damage during heart surgeries. Will's lab (www.goodyerlab.com) focuses on basic science advances aimed at the improved diagnosis and treatment of cardiac arrhythmias.

  • Deborah M Gordon

    Deborah M Gordon

    Paul S. and Billie Achilles Professor of Environmental Biology

    Current Research and Scholarly InterestsProfessor Deborah M Gordon studies the evolutionary ecology of collective behavior. Ant colonies operate without central control, using local interactions to regulate colony behavior.

  • Jorg Goronzy

    Jorg Goronzy

    Professor of Medicine (Immunology and Rheumatology), Emeritus

    Current Research and Scholarly InterestsT cell homeostasis and function with age

  • Ian Gotlib

    Ian Gotlib

    Marjorie Mhoon Fair Professor

    Current Research and Scholarly InterestsCurrent interests include social, cognitive, and biological factors in affective disorders; neural and cognitive processing of emotional stimuli and reward by depressed persons; behavioral activation and anhedonia in depression; social, emotional, and biological risk factors for depression in children.

  • Or Gozani

    Or Gozani

    Dr. Morris Herzstein Professor

    Current Research and Scholarly InterestsWe study the molecular mechanisms by which chromatin-signaling networks effect nuclear and epigenetic programs, and how dysregulation of these pathways leads to disease. Our work centers on the biology of lysine methylation, a principal chromatin-regulatory mechanism that directs epigenetic processes. We study how lysine methylation events are generated, sensed, and transduced, and how these chemical marks integrate with other nuclear signaling systems to govern diverse cellular functions.

  • Dita Gratzinger

    Dita Gratzinger

    Professor of Pathology

    Current Research and Scholarly InterestsI have research interests in the interaction of normal and neoplastic hematolymphoid cells with the bone marrow. lymph node and spleen microenvironment and the interactions of these compartments with immune perturbation and dysregulation.

  • Edward Graves

    Edward Graves

    Professor of Radiation Oncology (Radiation Physics), and by courtesy, of Radiology

    Current Research and Scholarly InterestsApplications of molecular imaging in radiation therapy, small animal image-guided conformal radiotherapy, immune responses to radiation, immunotherapy and radiotherapy combinations, image processing and analysis.

  • Nathanael S. Gray

    Nathanael S. Gray

    Krishnan-Shah Family Professor

    BioNathanael Gray is the Krishnan-Shah Family Professor of Chemical and Systems Biology at Stanford, Co-Director of Cancer Drug Discovery Co-Leader of the Cancer Therapeutics Research Program, Member of Chem-H, and Program Leader for Small Molecule Drug Discovery for the Innovative Medicines Accelerator (IMA). His research utilizes the tools of synthetic chemistry, protein biochemistry, and cancer biology to discover and validate new strategies for the inhibition of anti-cancer targets. Dr. Gray’s research has had broad impact in the areas of kinase inhibitor design and in circumventing drug resistance.
    Dr. Gray received his PhD in organic chemistry from the University of California at Berkeley in 1999 after receiving his BS degree with the highest honor award from the same institution in 1995. After completing his PhD, Dr. Gray was recruited to the newly established Genomics Institute of the Novartis Research Foundation (GNF) in San Diego, California. During his six year stay at GNF, Dr. Gray became the director of biological chemistry where he supervised a group of over fifty researchers integrating chemical, biological and pharmacological approaches towards the development of new experimental drugs. Some of the notable accomplishments of Dr. Gray’s team at GNF include: discovery of the first allosteric inhibitors of wild-type and mutant forms of BCR-ABL which resulted in clinical development of ABL001; discovery of the first selective inhibitors of the Anaplastic Lymphoma Kinase (ALK), an achievement that led to the development of now FDA-approved drugs such as ceritinib (LDK378) for the treatment of EML4-ALK expressing non-small cell lung cancer (NSCLC); and discovery that sphingosine-1-phosphate receptor-1 (S1P1) is the pharmacologically relevant target of the immunosuppressant drug Fingomilod (FTY720) followed by the development of Siponimod (BAF312), which is currently used for the treatment of multiple sclerosis.
    In 2006, Dr. Gray returned to academia as a faculty member at the Dana Farber Cancer Institute and Harvard Medical School in Boston. There, he has established a discovery chemistry group that focuses on developing first-in-class inhibitors for newly emerging biological targets, including resistant alleles of existing targets, as well as inhibitors of well-validated targets, such as Her3 and RAS, that have previously been considered recalcitrant to small molecule drug development. Dr. Gray’s team developed covalent inhibitors of the T790M mutant of EGFR inspired the development of Osimertinib (AZD9291), now FDA approved for treatment of patients with relapsed lung cancer due to resistance to first generation EGFR inhibitors. Dr. Gray has also developed structure-based, generalized approaches for designing drugs to overcome one of the most common mechanisms of resistance observed against most kinase inhibitor drugs, mutation of the so-called "gatekeeper" residue, which has been observed in resistance to drugs targeting BCR-ABL, c-KIT and PDGFR.
    In 2021, Dr. Gray joined Stanford University where he has joined the Stanford Cancer Institute, Chem-H and the Innovative Medicines Accelerator (IMA) to spur the development of prototype drugs.
    These contributions have been recognized through numerous awards including the National Science Foundation’s Career award in 2007, the Damon Runyon Foundation Innovator award in 2008, the American Association for Cancer Research for Team Science in 2010 and for Outstanding Achievement in 2011 and the American Chemical Society award for Biological Chemistry in 2011, and the Nancy Lurie Marks endowed professorship in 2015 and the Paul Marks Prize in 2019, and the Hope Funds for Cancer Research in 2023.

  • Henry T. (Hank) Greely

    Henry T. (Hank) Greely

    Deane F. and Kate Edelman Johnson Professor of Law and, Professor, by courtesy, of Genetics

    Current Research and Scholarly InterestsSince 1992 my work has concentrated on ethical, legal, and social issues in the biosciences. I am particularly active on issues arising from neuroscience, human genetics, and stem cell research, with cross-cutting interests in human research protections, human biological enhancement, and the future of human reproduction.

  • Sherril L. Green, DVM, PhD

    Sherril L. Green, DVM, PhD

    Professor of Comparative Medicine, Emerita

    Current Research and Scholarly InterestsResearch Interests: Xenopus laevis. Husbandry, biology, infectious and parasitic diseases of laboratory Xenopus laevis. Large animal models of disease.

  • Tamar Green

    Tamar Green

    Associate Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Sciences) and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsThe Brain Imaging, Development, and Genetic (BRIDGE) Lab focuses on disorders associated with child development, such as attention deficits, hyperactivity, and autism spectrum disorders. we aim to uncover biological principles of how genetic variation and its associated downstream pathways affect children's neurodevelopmental disorders.

  • Harry B Greenberg

    Harry B Greenberg

    Joseph D. Grant Professor in the School of Medicine, Emeritus

    Current Research and Scholarly InterestsMolecular mechanisms of pathogenesis; determinants of protective immunity; host range and tissue tropism in liver and GI tract pathogenic viruses and studies of vaccines in people.